John K. Cini

Chief Scientific Officer, Sonnet BioTherapeutics Holdings, Inc.

Companies

Sonnet BioTherapeutics Holdings, Inc.Board member Dec 3, 2025 to now¹
Sonnet BioTherapeutics Holdings, Inc.Chief Scientific Officer Apr 3, 2020 to now²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 2, 2025Returned to company 14,116 shares of Sonnet BioTherapeutics Holdings, Inc.³
Jul 11, 2025Granted 12,000 shares of Sonnet BioTherapeutics Holdings, Inc.⁴
Dec 11, 2023Granted 1,888 shares of Sonnet BioTherapeutics Holdings, Inc.⁵
Jan 7, 2023Granted 18,551 shares of Sonnet BioTherapeutics Holdings, Inc.⁶
Jan 7, 2023Returned to company 18,551 shares of Sonnet BioTherapeutics Holdings, Inc.⁶
Dec 14, 2022Granted 18,551 shares of Sonnet BioTherapeutics Holdings, Inc.⁷
Dec 15, 2021Granted 80,034 shares of Sonnet BioTherapeutics Holdings, Inc.⁸

The numbers on this page point here. Each one links to the record it came from.